# mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer

> **NCT05480280** · PHASE2 · UNKNOWN · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 18 (estimated)

## Conditions studied

- Advanced/Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Dalpiciclib
- **DRUG:** Oxaliplatin injection
- **DRUG:** Calcium folinate
- **DRUG:** 5-fluorouracil

## Key facts

- **NCT ID:** NCT05480280
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-20
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05480280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05480280, "mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05480280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*